NDC properties for "Sulfatrim" (RxCUI 208406)
About this data
The tables show NDC propoerties for Sulfatrim with the RxCUI 208406
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Sulfatrim (RxCUI 208406)
| MMSL_CODE | BD3234 |
|---|---|
| NDA | NDA018615 |
| RxCUI | 208406 |
| SPL_SET_ID | 943ea381-7902-4ce9-abad-4270ebde9d3c |
| SPL_SET_ID | b339af0b-4fa2-e8c3-e053-2995a90a6a34 |
| SPL_SET_ID | c62086ea-ba15-40f5-8431-4639c60c9825 |
| SPL_SET_ID | cd4932ce-0856-4e99-8baf-70afce1d7ffd |
| Prescribable Synonym | SULFATRIM 200 MG / 40 MG in 5 mL Oral Suspension |
| RXNAV_STR | SMX 40 MG/ML / TMP 8 MG/ML Oral Suspension [Sulfatrim] |
| RxNorm Name | sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension [Sulfatrim] |
| RxNorm Synonym | SMX 40 MG/ML / TMP 8 MG/ML Oral Suspension [Sulfatrim] |
| RxNorm Synonym | Sulfatrim (sulfamethoxazole 200 MG / trimethoprim 40 MG) per 5 ML Oral Suspension |
| Related queries | Interactions (for RxCUI 208406) |
NDC Properties
NDC Item 00121085416
| NDC 9 | 0121-0854 |
|---|---|
| NDC 10 | 0121-0854-16 |
| NDC Item | 00121085416 |
| Packaging | 473 mL in 1 BOTTLE (0121-0854-16) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 794045 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-03 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0854 |
NDC Item 54879000716
| NDC 9 | 54879-007 |
|---|---|
| NDC 10 | 54879-007-16 |
| NDC Item | 54879000716 |
| Packaging | 473 mL in 1 BOTTLE (54879-007-16) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 110421 |
| Labeler | STI Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 54879-007 |
NDC Item 67296165701
| NDC 9 | 67296-1657 |
|---|---|
| NDC 10 | 67296-1657-1 |
| NDC Item | 67296165701 |
| Packaging | 100 mL in 1 BOTTLE (67296-1657-1) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 799421 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 67296-1657 |
NDC Item 67296165702
| NDC 9 | 67296-1657 |
|---|---|
| NDC 10 | 67296-1657-2 |
| NDC Item | 67296165702 |
| Packaging | 200 mL in 1 BOTTLE (67296-1657-2) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 799421 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 67296-1657 |
NDC Item 68788734504
| NDC 9 | 68788-7345 |
|---|---|
| NDC 10 | 68788-7345-4 |
| NDC Item | 68788734504 |
| Packaging | 473 mL in 1 BOTTLE (68788-7345-4) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 731241 |
| Labeler | Preferred Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-06-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 68788-7345 |
NDC Item 00121085416
| NDC 9 | 0121-0854 |
|---|---|
| NDC 10 | 0121-0854-16 |
| NDC Item | 00121085416 |
| Packaging | 473 mL in 1 BOTTLE (0121-0854-16) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 794045 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-03 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0854 |
NDC Item 54879000716
| NDC 9 | 54879-007 |
|---|---|
| NDC 10 | 54879-007-16 |
| NDC Item | 54879000716 |
| Packaging | 473 mL in 1 BOTTLE (54879-007-16) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 110421 |
| Labeler | STI Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 54879-007 |
NDC Item 67296165701
| NDC 9 | 67296-1657 |
|---|---|
| NDC 10 | 67296-1657-1 |
| NDC Item | 67296165701 |
| Packaging | 100 mL in 1 BOTTLE (67296-1657-1) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 799421 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 67296-1657 |
NDC Item 67296165702
| NDC 9 | 67296-1657 |
|---|---|
| NDC 10 | 67296-1657-2 |
| NDC Item | 67296165702 |
| Packaging | 200 mL in 1 BOTTLE (67296-1657-2) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 799421 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 67296-1657 |
NDC Item 68788734504
| NDC 9 | 68788-7345 |
|---|---|
| NDC 10 | 68788-7345-4 |
| NDC Item | 68788734504 |
| Packaging | 473 mL in 1 BOTTLE (68788-7345-4) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 731241 |
| Labeler | Preferred Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-06-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 68788-7345 |
NDC Item 00121085416
| NDC 9 | 0121-0854 |
|---|---|
| NDC 10 | 0121-0854-16 |
| NDC Item | 00121085416 |
| Packaging | 473 mL in 1 BOTTLE (0121-0854-16) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 794045 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-03 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0854 |
NDC Item 54879000716
| NDC 9 | 54879-007 |
|---|---|
| NDC 10 | 54879-007-16 |
| NDC Item | 54879000716 |
| Packaging | 473 mL in 1 BOTTLE (54879-007-16) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 110421 |
| Labeler | STI Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 54879-007 |
NDC Item 67296165701
| NDC 9 | 67296-1657 |
|---|---|
| NDC 10 | 67296-1657-1 |
| NDC Item | 67296165701 |
| Packaging | 100 mL in 1 BOTTLE (67296-1657-1) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 799421 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 67296-1657 |
NDC Item 67296165702
| NDC 9 | 67296-1657 |
|---|---|
| NDC 10 | 67296-1657-2 |
| NDC Item | 67296165702 |
| Packaging | 200 mL in 1 BOTTLE (67296-1657-2) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 799421 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 67296-1657 |
NDC Item 68788734504
| NDC 9 | 68788-7345 |
|---|---|
| NDC 10 | 68788-7345-4 |
| NDC Item | 68788734504 |
| Packaging | 473 mL in 1 BOTTLE (68788-7345-4) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 731241 |
| Labeler | Preferred Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-06-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 68788-7345 |
NDC Item 00121085416
| NDC 9 | 0121-0854 |
|---|---|
| NDC 10 | 0121-0854-16 |
| NDC Item | 00121085416 |
| Packaging | 473 mL in 1 BOTTLE (0121-0854-16) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 794045 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-03 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0854 |
NDC Item 54879000716
| NDC 9 | 54879-007 |
|---|---|
| NDC 10 | 54879-007-16 |
| NDC Item | 54879000716 |
| Packaging | 473 mL in 1 BOTTLE (54879-007-16) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 110421 |
| Labeler | STI Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 54879-007 |
NDC Item 67296165701
| NDC 9 | 67296-1657 |
|---|---|
| NDC 10 | 67296-1657-1 |
| NDC Item | 67296165701 |
| Packaging | 100 mL in 1 BOTTLE (67296-1657-1) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 799421 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 67296-1657 |
NDC Item 67296165702
| NDC 9 | 67296-1657 |
|---|---|
| NDC 10 | 67296-1657-2 |
| NDC Item | 67296165702 |
| Packaging | 200 mL in 1 BOTTLE (67296-1657-2) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 799421 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 67296-1657 |
NDC Item 68788734504
| NDC 9 | 68788-7345 |
|---|---|
| NDC 10 | 68788-7345-4 |
| NDC Item | 68788734504 |
| Packaging | 473 mL in 1 BOTTLE (68788-7345-4) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 731241 |
| Labeler | Preferred Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-06-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 68788-7345 |
NDC Item 00121085416
| NDC 9 | 0121-0854 |
|---|---|
| NDC 10 | 0121-0854-16 |
| NDC Item | 00121085416 |
| Packaging | 473 mL in 1 BOTTLE (0121-0854-16) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 794045 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-03 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0854 |
NDC Item 54879000716
| NDC 9 | 54879-007 |
|---|---|
| NDC 10 | 54879-007-16 |
| NDC Item | 54879000716 |
| Packaging | 473 mL in 1 BOTTLE (54879-007-16) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 110421 |
| Labeler | STI Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 54879-007 |
NDC Item 67296165701
| NDC 9 | 67296-1657 |
|---|---|
| NDC 10 | 67296-1657-1 |
| NDC Item | 67296165701 |
| Packaging | 100 mL in 1 BOTTLE (67296-1657-1) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 799421 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 67296-1657 |
NDC Item 67296165702
| NDC 9 | 67296-1657 |
|---|---|
| NDC 10 | 67296-1657-2 |
| NDC Item | 67296165702 |
| Packaging | 200 mL in 1 BOTTLE (67296-1657-2) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 799421 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1983-07-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 67296-1657 |
NDC Item 68788734504
| NDC 9 | 68788-7345 |
|---|---|
| NDC 10 | 68788-7345-4 |
| NDC Item | 68788734504 |
| Packaging | 473 mL in 1 BOTTLE (68788-7345-4) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 731241 |
| Labeler | Preferred Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-06-01 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 68788-7345 |